Q#1 The LEAST common clinical presentation of COVID-19 infection is: A- Severe B- Mildly symptomatic

Q#1 The LEAST common clinical presentation of COVID-19 infection is:
A- Severe
B- Mildly symptomatic without pneumonia
C- Mildly symptomatic with pneumonia
D- Moderately symptomatic with pneumonia
E- Critical
Q#2 A hospitalized individual with severe SARS-CoV-2 infection is infused with a cocktail of two monoclonal antibodies (MAbs) to SARS-CoV-2. Unfortunately, the patient remains very sick and is not helped by the monoclonal antibodies. What might account for this lack of response?
A- The patient has depressed (low) levels of B cells in circulation and in germinal centers
B- The patient has low levels of IL-6 production in response to the infusion
C- The virus has mutated and no longer expresses the epitopes targeted by the MAbs
D- The patient makes a good IgM response to the infused MAbs but fails to make IgG and IgA
E- The patient has a deficient presentation of viral antigen by dendritic cells to CD4 T cells
Q#3 Which of the following responses is associated with poor viral clearance and severe and fatal COVID-19?
A- Immediate NK cell activation
B- Early T cell activation
C- Delayed T cell activation
D- Early B cell activation E Early antibody production
Q#4 Most journals generally require the following person(s) to file a disclosure with respect to a manuscript submitted for review and possible publication:
A- The editor-in chief.
B- The editor tasked with the manuscript.
C- The persons selected to do the peer review.
D- The student author(s).
E- All persons cited in the acknowledgements.

Place this order or similar order and get an amazing discount. USE Discount code “GET20” for 20% discount